Pharma Co. RevitaLid Approved For Ch. 11 Equity Swap Plan
Drug company RevitaLid Pharmaceutical Corp. received court approval Monday for its prepackaged Chapter 11 plan that will swap $80 million of its prepetition secured debt for most of the equity in...To view the full article, register now.
Already a subscriber? Click here to view full article